已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Short-Term Morphofunctional Changes in Previously Treated Neovascular AMD Eyes Switched to Brolucizumab

医学 阿柏西普 眼科 血管抑制剂 脉络膜新生血管 血管性 视力 黄斑变性 贝伐单抗 外科 化疗
作者
Pasquale Viggiano,Maria Oliva Grassi,Giacomo Boscia,Mariagrazia Pignataro,Giovanni Petruzzella,Enrico Borrelli,Teresa Molfetta,Giovanni Alessio,Francesco Boscia
出处
期刊:Journal of Clinical Medicine [Multidisciplinary Digital Publishing Institute]
卷期号:11 (19): 5517-5517 被引量:7
标识
DOI:10.3390/jcm11195517
摘要

The purpose of the study is to explore the morphofunctional fluctuations in eyes treated for neovascular AMD (nAMD) when treatment is switched from aflibercept or ranibizumab to brolucizumab. A total of 31 eyes of 31 patients with nAMD with type 1 macular neovascularization (MNV) were included. All patients were imaged using spectral domain optical coherence tomography (SD-OCT). The OCT acquisition was performed at the following visits: (i) “T1 visit” corresponding to the last follow-up examination in which an intravitreal injection of aflibercept or ranibizumab was performed before switching to brolucizumab because of the lack of improvement and (ii) “T2 visit” corresponding to the examination performed 1 month after T1, the latter visit corresponding to the day when a switch to brolucizumab injection was performed, (iii) and 1 month after the latter injection “(T3)”. The main outcome measures were: (1) central macular thickness (CMT), (2) choroidal vascularity index (CVI), (3) subfoveal choroidal thickness (CT), and best-corrected visual acuity (BCVA). Functional outcome showed significant differences at each time. Mean ± SD BCVA was 0.43 ± 0.12 LogMAR at T1 and 0.56 ± 0.16 LogMAR at T2 (p = 0.038). A significant improvement in BCVA was displayed at T3 (0.34 ± 0.21 LogMAR) as compared with T2 (p = 0.019). CMT analysis showed fluctuations three times. In detail, T2 displayed a thicker CMT in comparison with T1, although not statistically significant (p = 0.12). Contrariwise, T3 showed a thinner CMT in comparison with T2 (p = 0.002). Analyzing CVI among the three different times, the luminal choroidal area (LCA) and total choroidal area (TCA) showed significantly different values before and after switching to brolucizumab. T2 showed a significant reduction in both vessel lumen and total area compared with T1 (p = 0.032 and p = 0.046, respectively). Moreover, T3 showed a greater value of both LCA and TCA in comparison with T2 (p = 0.008 and p = 0.01, respectively). CT did not show significant differences at each time (p > 0.05). Our results reported early experiences on morphofunctional fluctuations in patients with nAMD who switched to brolucizumab. The anatomical impact of brolucizumab administration appears to result in choroidal vascular enlargement, accompanied by the resolution of subretinal fluid (SRF) and intraretinal fluid (IRF).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
fly发布了新的文献求助10
1秒前
爱听歌凤灵完成签到 ,获得积分10
2秒前
lxl98完成签到 ,获得积分10
3秒前
4秒前
lwh104完成签到,获得积分10
5秒前
6秒前
7秒前
顺利秋灵发布了新的文献求助10
9秒前
漂亮白枫发布了新的文献求助10
9秒前
dzk完成签到,获得积分10
10秒前
asdfghjkl完成签到,获得积分20
10秒前
番茄黄瓜芝士片完成签到 ,获得积分10
10秒前
风趣的老太应助YDX采纳,获得10
13秒前
凌七发布了新的文献求助10
14秒前
王旭东完成签到 ,获得积分10
15秒前
犹豫的夏旋完成签到 ,获得积分10
15秒前
BBH完成签到,获得积分10
16秒前
Lee发布了新的文献求助10
16秒前
禾苗完成签到 ,获得积分10
19秒前
20秒前
林洁佳完成签到,获得积分10
22秒前
淡然平蓝完成签到 ,获得积分10
26秒前
西瓜刀完成签到 ,获得积分10
26秒前
领导范儿应助BBH采纳,获得10
26秒前
凌七完成签到,获得积分10
28秒前
bkagyin应助漂亮白枫采纳,获得10
33秒前
野猪大王完成签到 ,获得积分10
34秒前
咚咚完成签到 ,获得积分10
36秒前
Sunsets完成签到 ,获得积分10
38秒前
不与仙同完成签到 ,获得积分10
39秒前
Steven发布了新的文献求助10
42秒前
满唐完成签到 ,获得积分10
44秒前
棣棣完成签到,获得积分10
44秒前
Lee完成签到,获得积分10
45秒前
清爽笑翠完成签到 ,获得积分10
45秒前
沐风完成签到,获得积分20
47秒前
51秒前
英姑应助合适的台灯采纳,获得10
54秒前
55秒前
吾系渣渣辉完成签到 ,获得积分10
56秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976583
求助须知:如何正确求助?哪些是违规求助? 3520659
关于积分的说明 11204399
捐赠科研通 3257298
什么是DOI,文献DOI怎么找? 1798683
邀请新用户注册赠送积分活动 877842
科研通“疑难数据库(出版商)”最低求助积分说明 806595